Tourmaline Bio surges after Novartis $1.4 billion acquisition; analysts see strong fit

Shares of Tourmaline Bio surged in premarket trading on Tuesday after the US-based biotechnology company agreed to be acquired by Swiss pharmaceutical major Novartis for approximately $1.4 billion. Tourmaline shares…